July 24, 2017 09:59 AM EDT

Samsung Bioepis launches a Remicade knockoff at a 35% discount; FDA OK’s a self-administered version of Benlysta

→ The South Korean biosimilar player Samsung Bioepis has launched a copycat of Remicade on the US market at a 35% discount to …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Sam­sung Bioepis launch­es a Rem­i­cade knock­off at a 35% dis­count; FDA OK’s a self-ad­min­is­tered ver­sion of Benlysta